Injective Price Surge: Smart Money Loading Up as Bulls Eye $5.39
Injective (INJ) is trading at $5.12 after a 4.32% intraday gain, sitting above major moving averages while MACD momentum hovers at zero.
The market context suggests that INJ's relative undervaluation against its on-chain utility is driving the price up. The structural setup shows that price is trading above all major moving averages simultaneously, indicating a constructive trend across every relevant timeframe.
However, technical indicators are not screaming, but rather promising. Momentum has flatlined at the MACD crossover, and the Stochastic oscillator is recovering from deeply oversold territory. The Bollinger Band setup suggests that INJ has theoretical room to run nearly $0.65 to the upside before hitting band resistance.
What's concerning short-term is aggressive sell volume outpacing buy volume on a 1-hour basis, with buyers representing only 47% of executed trades. Top traders are sitting 54.3% net long on INJ futures, while retail participants are leaning bearish on the margin.